|
NFIA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.03570000020703E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.239730E-02 |
| Stage1-vs-Stage3 |
5.902400E-02 |
| Stage1-vs-Stage4 |
2.352400E-04 |
| Stage2-vs-Stage3 |
1.100410E-03 |
| Stage2-vs-Stage4 |
6.56540000032457E-07 |
| Stage3-vs-Stage4 |
6.448200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.09409999948795E-07 |
| Normal-vs-Asian |
1.75426340121021E-12 |
| Caucasian-vs-AfricanAmerican |
4.506800E-01 |
| Caucasian-vs-Asian |
4.395800E-01 |
| AfricanAmerican-vs-Asian |
8.227800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.273000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62925228863742E-12 |
| Normal-vs-Age(81-100Yrs) |
3.1175000000383E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.628400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.417000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.089400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.886800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.462200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.523800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.02649999956084E-07 |
| Classical-VS-Follicular |
3.5527136788005E-14 |
| Classical-VS-Other |
6.095000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
<1E-12 |
| Tall-VS-Other |
6.456000E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.924170E-03 |
| Follicular-VS-Normal |
4.00849999999675E-05 |
| Other-VS-Normal |
1.82165000000012E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.57651669496772E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.68450000000476E-05 |
|
|
